| 中文名称 | (2R,3R,4S,5S,6R)-2-(((1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-2-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-7-羟基-8-((Z)-5-羟基-4-甲基戊-3-烯-1-基)-8-(羟甲基)-1,4a,10a,10b-四甲基十八氢屈-1-基)甲氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇 |
|---|---|
| 中文别名 | 凤仙萜四醇苷G;凤仙萜四醇皂苷G |
| 英文名称 | (2R,3R,4S,5S,6R)-2-(((1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-7-hydroxy-8-((Z)-5-hydroxy-4-methylpent-3-en-1- |
| 英文别名 | b-D-Glucopyranoside,(1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-1-[(b-D-glucopyranosyloxy)methyl]octadecahydro-7-hydroxy-8-(hydroxymethyl)-8-[(3Z)-5-hydroxy-4-methyl-3-pentenyl]-1,4a,10a,10b-tetramethyl-2-chrysenyl2-O-b-D-xylopyranosyl- (9CI);Hosenkoside G;b-D-Glucopyranoside,(1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-1-[(b-D-glucopyranosyloxy)methyl]octadecahydro-7-hydroxy-8-(hydr;b-D-Glucopyranoside,(1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-1-[(b-D-glucopyranosyloxy)methyl]octadecahydro-7-hydroxy-8-(hydroxymethyl)-8-[(3Z)-5-hydroxy-4-methyl-3-pentenyl]-1,4a,10a,10b-tetramethyl-;(+)-Hosenkoside G;b-D-Glucopyranoside, (3b,4a,18b,19Z)-23-(b-D-glucopyranosyloxy)-18,28,29-trihydroxy-18,19-secolup-19-en-3-yl2-O-b-D-xylopyranosyl-;2-[[(1R,4Ar,4bS,6aR,8R,10aR,10bR,12aR)-2-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxyoxan-2-;(2R,3R,4S,5S,6R)-2-[[(1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(h |
| CAS号 | 160896-46-8 |
| 分子式 | C47H80O19 |
| 分子量 | 949.13 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
